Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Beginning July 1, 2026, eligible Medicare beneficiaries can access four GLP-1 weight-loss medications through the temporary Medicare GLP-1 Bridge Program: Wegovy injections, Wegovy tablets, Zepbound KwikPen, and Foundayo
Hafner A, et al
David Rometo joined healthcare leaders from around the world in contributing to the iFHP | International Federation of Health Plans white paper, Rethinking the Obesity Challenge. The paper explores: * Why obesity must be treated as a chronic, multifactorial disease * Why GLP-1s are only part of the answer * How insurers can move from payer to building a team around the patient * Why weight management needs to focus on wider health outcomes, not just weight loss * What partnerships are needed to tackle obesity at scale See more:
Still, if symptoms persist or interfere with your daily life, its important to talk to your doctor who can adjust your treatment plan
US$ 27.11
US$ 24.76
US$ 22.76
US$ 21.35
US$ 24.68
US$ 22.50
